Chemotherapy in the management of squamous-cell carcinoma of the head and neck
- 1 May 2001
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 2 (5), 261-269
- https://doi.org/10.1016/s1470-2045(00)00320-x
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Natural history of untreated head and neck cancerEuropean Journal Of Cancer, 2000
- A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neckBritish Journal of Cancer, 1999
- Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neckCancer, 1998
- Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neckAnnals Of Oncology, 1998
- Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neckAnnals of Oncology, 1997
- Docetaxel: an active drug for squamous cell carcinoma of the head and neck.Journal of Clinical Oncology, 1996
- Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neckAnnals of Oncology, 1994
- Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neckAnnals Of Oncology, 1994
- Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.Journal of Clinical Oncology, 1992
- A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neckBritish Journal of Cancer, 1990